Olopatadine 70069-0017
Product NDC
70069-0017- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- April 15, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA206306
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 1 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(1)
1 BOTTLE, PLASTIC in 1 CARTON (70069-017-01) / 5 mL in 1 BOTTLE, PLASTIC